"The complexity of drugs and their delivery has been increasing over the past few decades. Combined with a growing prevalence of chronic illnesses, this market evolution is putting more pressure on pharmaceutical manufacturers to develop novel therapies that might also have unique formulation needs.”
Peter Droc, Head of Drug Product Services at Lonza, recently shared his thoughts on the solutions to increasingly complex formulation needs, and how these can ensure quality and patient safety, while also decreasing time-to-market.
Belinda Holdsworth, Strategic Growth Project Lead for DPS at Lonza, also emphasized how a robust visual inspection process which utilizes AI and automated robotics can greatly enhance process timelines.
Read the full article here: https://lnkd.in/eds3Xnkw
#AHealthierWorld #DrugProduct #LonzaDPS
CEO at VENKATA LIFE SCIENCE PRIVATE LIMITED
3wPlease post the proceedings